Investments
751Portfolio Exits
130Funds
17Partners & Customers
10Service Providers
1About ARCH Venture Partners
ARCH Venture Partners runs a venture capital firm. It provides seed and early-stage venture capital for technology firms, with a special competence in co-founding and building firms from start-ups. It aims to deliver promising technologies from the earliest stages to successful commercial applications from concept to commerce. ARCH Venture Partners was founded in 1986 and is based in Chicago, Illinois.
Expert Collections containing ARCH Venture Partners
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find ARCH Venture Partners in 1 Expert Collection, including Synthetic Biology.
Synthetic Biology
382 items
Research containing ARCH Venture Partners
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned ARCH Venture Partners in 1 CB Insights research brief, most recently on Jul 14, 2023.
Latest ARCH Venture Partners News
Nov 11, 2025
Matthew Herper covers medical innovation — both its promise and its perils. Mergers and acquisitions are a spectator sport. You couldn’t hope for a better match to watch than the competition between Pfizer and Novo Nordisk over Metsera , a rollup of several experimental weight loss drugs founded three years ago. It had political intrigue, Big Pharma gamesmanship, and suspense, until Pfizer triumphed with a $10 billion offer . But beyond Pfizer getting an obesity pipeline, what does it all mean? Advertisement Well, several venture funds stand to make big profits, with Population Health Partners and ARCH Venture Partners each pocketing more than $1 billion from the deal. That likely only increases the appetite of biotech investors to bet on the next thing. But keep in mind the deal offers some lessons that could — or perhaps should — instill some caution. STAT+ Exclusive Story
ARCH Venture Partners Investments
751 Investments
ARCH Venture Partners has made 751 investments. Their latest investment was in Lifordi Immunotherapeutics as part of their Series A - II on November 18, 2025.
ARCH Venture Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
11/18/2025 | Series A - II | Lifordi Immunotherapeutics | $42M | No | 1 | |
11/13/2025 | Series B | Gate Bioscience | $65M | No | a16z Bio Health, Eli Lilly and Company, Forbion, Google Ventures, and Versant Ventures | 3 |
11/6/2025 | Series D | Synchron | $200M | No | Bezos Expeditions, Double Point Ventures, IQT, K5 Global Technology, Khosla Ventures, METIS Innovative, National Reconstruction Fund Corporation, Neuro Technology Investors, Protocol Labs Venture, Qatar Investment Authority, and T.Rx Capital | 2 |
11/6/2025 | Series C - II | |||||
10/15/2025 | Series B |
Date | 11/18/2025 | 11/13/2025 | 11/6/2025 | 11/6/2025 | 10/15/2025 |
|---|---|---|---|---|---|
Round | Series A - II | Series B | Series D | Series C - II | Series B |
Company | Lifordi Immunotherapeutics | Gate Bioscience | Synchron | ||
Amount | $42M | $65M | $200M | ||
New? | No | No | No | ||
Co-Investors | a16z Bio Health, Eli Lilly and Company, Forbion, Google Ventures, and Versant Ventures | Bezos Expeditions, Double Point Ventures, IQT, K5 Global Technology, Khosla Ventures, METIS Innovative, National Reconstruction Fund Corporation, Neuro Technology Investors, Protocol Labs Venture, Qatar Investment Authority, and T.Rx Capital | |||
Sources | 1 | 3 | 2 |
ARCH Venture Partners Portfolio Exits
130 Portfolio Exits
ARCH Venture Partners has 130 portfolio exits. Their latest portfolio exit was Orbital Therapeutics on October 10, 2025.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
10/10/2025 | Acquired | 9 | |||
8/7/2025 | Acquired | 7 | |||
1/31/2025 | IPO | Public | 2 | ||
Date | 10/10/2025 | 8/7/2025 | 1/31/2025 | ||
|---|---|---|---|---|---|
Exit | Acquired | Acquired | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 9 | 7 | 2 |
ARCH Venture Partners Acquisitions
1 Acquisition
ARCH Venture Partners acquired 1 company. Their latest acquisition was Caliper Life Sciences on May 01, 1998.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
5/1/1998 | Private Equity | $37.09M | Acquired |
Date | 5/1/1998 |
|---|---|
Investment Stage | Private Equity |
Companies | |
Valuation | |
Total Funding | $37.09M |
Note | Acquired |
Sources |
ARCH Venture Partners Fund History
17 Fund Histories
ARCH Venture Partners has 17 funds, including ARCH Venture Fund XIII.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
9/26/2024 | ARCH Venture Fund XIII | $3,000M | 2 | ||
6/29/2022 | ARCH Venture Fund XII | $3,000M | 1 | ||
1/28/2021 | ARCH Venture Fund XI | $1,850M | 2 | ||
10/28/2019 | ARCH Venture Fund X | ||||
10/25/2019 | ARCH Venture Fund X Overage |
Closing Date | 9/26/2024 | 6/29/2022 | 1/28/2021 | 10/28/2019 | 10/25/2019 |
|---|---|---|---|---|---|
Fund | ARCH Venture Fund XIII | ARCH Venture Fund XII | ARCH Venture Fund XI | ARCH Venture Fund X | ARCH Venture Fund X Overage |
Fund Type | |||||
Status | |||||
Amount | $3,000M | $3,000M | $1,850M | ||
Sources | 2 | 1 | 2 |
ARCH Venture Partners Partners & Customers
10 Partners and customers
ARCH Venture Partners has 10 strategic partners and customers. ARCH Venture Partners recently partnered with JW Group on July 7, 2022.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
7/13/2022 | Partner | JW Group | JW ties up with US venture capitalist for ‘R&D open innovation’ The JW Group partnered with U.S. venture capital ARCH Venture Partners to strengthen global open innovation . | 1 | |
Partner | United States | 1 | |||
Partner | Iceland | 1 | |||
Partner | |||||
Partner |
Date | 7/13/2022 | ||||
|---|---|---|---|---|---|
Type | Partner | Partner | Partner | Partner | Partner |
Business Partner | JW Group | ||||
Country | United States | Iceland | |||
News Snippet | JW ties up with US venture capitalist for ‘R&D open innovation’ The JW Group partnered with U.S. venture capital ARCH Venture Partners to strengthen global open innovation . | ||||
Sources | 1 | 1 | 1 |
ARCH Venture Partners Team
14 Team Members
ARCH Venture Partners has 14 team members, including current Founder, Managing Director, Keith L. Crandell.
Name | Work History | Title | Status |
|---|---|---|---|
Keith L. Crandell | Founder, Managing Director | Current | |
Name | Keith L. Crandell | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Founder, Managing Director | ||||
Status | Current |
Compare ARCH Venture Partners to Competitors
Venrock operates as a venture capital firm with a primary focus on technology and healthcare sectors. The company collaborates with entrepreneurs to support the development of companies by providing financial resources and advice. Venrock's portfolio includes a range of companies from Apple Computer to Gilead Sciences. It was founded in 1969 and is based in Palo Alto, California.
Lightspeed Venture Partners invests in the enterprise, consumer, health, and financial technology sectors. The firm provides funding and support to entrepreneurs at various stages of their development. Lightspeed Venture Partners serves the startup ecosystem by offering financial resources and industry knowledge to companies within its targeted sectors. It was founded in 2000 and is based in Menlo Park, California.
Bessemer Venture Partners operates in the technology sectors and supports entrepreneurs in building companies. The company provides funding and guidance to startups at various growth stages, particularly in the enterprise, consumer, and healthcare areas. Its investment portfolio includes sectors such as artificial intelligence (AI) and machine learning (ML), biotechnology, cloud computing, consumer products, cybersecurity, fintech, and vertical software. It was founded in 1911 and is based in San Francisco, California.
Andreessen Horowitz invests in technology companies across various stages and sectors, including consumer, enterprise, bio/healthcare, crypto, fintech, and games industries. It was founded in 2009 and is based in Menlo Park, California.
Polaris Partners focuses on technology and healthcare sectors. The company invests in entrepreneurs and supports them in building companies. Polaris Partners primarily serves startups in these industries. Polaris Partners was formerly known as Polaris Venture Partners. It was founded in 1996 and is based in Boston, Massachusetts.
Sequoia Capital operates as a venture capital firm focused on supporting startups from inception to initial public offering (IPO) within sectors. It provides investment funding and strategic support to help companies grow and succeed. Sequoia Capital primarily serves technology-driven sectors and businesses aiming to become market leaders. It was founded in 1972 and is based in Menlo Park, California.
Loading...